(Q37980015)

26 August 2017

title

HCC: current surgical treatment concepts (English)

1 reference

26 August 2017

main subject

hepatocellular carcinoma

1 reference

F Cauchy

1

1 reference

26 August 2017

D Fuks

series ordinal

2

1 reference

26 August 2017

J Belghiti

series ordinal

3

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 June 2012

1 reference

Langenbeck's Archives of Surgery

26 August 2017

published in

1 reference

26 August 2017

volume

397

1 reference

26 August 2017

issue

5

1 reference

26 August 2017

page(s)

681-695

1 reference

https://scigraph.springernature.com/pub.10.1007/s00423-012-0911-2

26 August 2017

exact match

0 references

cites work

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Hepatocellular carcinoma: current management and perspectives for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Diagnosis and Treatment of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Current strategy for staging and treatment: the BCLC update and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Resection prior to liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Is surgery for large hepatocellular carcinoma justified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Resection of hepatocellular carcinoma in patients without cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Place of liver transplantation in the treatment of hepatocellular carcinoma in the normal liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

The surgical approach to HCC: our progress and results in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Surgical strategies for hepatocellular carcinoma with special reference to anatomical hepatic resection and intraoperative contrast-enhanced ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Computer-assisted surgery planning for complex liver resections: when is it helpful? A single-center experience over an 8-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Evaluation of liver function for hepatic resection for hepatocellular carcinoma in the liver with damaged parenchyma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Liver functional reserve estimation: state of the art and relevance for local treatments: the Eastern perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Laparoscopic liver resection for hepatocellular carcinoma in cirrhosis: long-term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Platelet-derived serotonin mediates liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Remnant liver volume to body weight ratio > or =0.5%: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Comparison of two methods of future liver remnant volume measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Increase in future remnant liver function after preoperative portal vein embolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Preoperative estimation of remnant hepatic function using fusion images obtained by (99m)Tc-labelled galactosyl-human serum albumin liver scintigraphy and computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Relationship between the histological degrees of hepatitis and the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Spontaneous tumour rupture and prognosis in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Clinical features and treatment outcome of advanced hepatocellular carcinoma with inferior vena caval invasion or atrial tumor thrombus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Portal vein thrombosis and arterioportal shunts: effects on tumor response after chemoembolization of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Right hepatectomy by the anterior method with liver hanging versus conventional approach for large hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Continuous versus intermittent portal triad clamping for liver resection: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Safety of prolonged intermittent pringle maneuver during hepatic resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

The international position on laparoscopic liver surgery: The Louisville Statement, 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Laparoscopic hepatectomy for hepatocellular carcinoma: a European experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Percutaneous transhepatic portography for the treatment of early portal vein thrombosis after surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

What should physicians look for in evaluating prognostic gene-expression signatures?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Which matters most: number of tumors, size of the largest tumor, or total tumor volume?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Strategies for safer liver surgery and partial liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

MELD score predicts 1-year patient survival post-orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Treatment before liver transplantation for HCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma: differences between young and elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Comparison between observed survival after resection of transplantable hepatocellular carcinoma and predicted survival after listing through a Markov model simulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-012-0911-2

A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma

1 reference

12 December 2020

Regeneration of the un-embolized liver parenchyma following portal vein embolization

1 reference

12 December 2020

Impaired systemic immunity and frequent infection in patients with Candida antigen after hepatectomy

1 reference

12 December 2020

Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter

1 reference

12 December 2020

Report of the 15th follow-up survey of primary liver cancer

1 reference

12 December 2020

Portal vein embolization before right hepatectomy: prospective clinical trial

1 reference

12 December 2020

Management of hepatocellular carcinoma

1 reference

12 December 2020

A simulation modelling approach to evaluating alternative policies for the management of the waiting list for liver transplantation

1 reference

12 December 2020

Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States

1 reference

12 December 2020

A new technical aspect of ultrasound-guided liver surgery

1 reference

12 December 2020

Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma

1 reference

12 December 2020

The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy

1 reference

12 December 2020

Laparoscopic and hand-assisted liver resection: preliminary results at a mid-sized hospital

1 reference

12 December 2020

Risk factors of ascites after hepatectomy for patients with hepatocellular carcinoma and hepatitis B virus-associated cirrhosis

1 reference

12 December 2020

Anterior approach for difficult major right hepatectomy.

1 reference

12 December 2020

Prospective validation of the "fifty-fifty" criteria as an early and accurate predictor of death after liver resection in intensive care unit patients

1 reference

12 December 2020

Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis

1 reference

12 December 2020

Laparoscopic staging and radiofrequency of hepatocellular carcinoma in liver ci rrhosis. A "bridge" treatment to liver transplantation.

1 reference

12 December 2020

Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs

1 reference

12 December 2020

Anterior approach for major right hepatic resection for large hepatocellular carcinoma

1 reference

12 December 2020

Postoperative liver function after elective right hepatectomy in elderly patients

1 reference

12 December 2020

Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma

1 reference

12 December 2020

High preoperative serum alanine transferase levels: effect on the risk of liver resection in Child grade A cirrhotic patients

1 reference

12 December 2020

Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy

1 reference

12 December 2020

Resection of hepatocellular carcinoma: a European experience on 328 cases.

1 reference

12 December 2020

Portal hypertension: contraindication to liver surgery?

1 reference

12 December 2020

Predictors of Long-Term Survival After Liver Transplantation for Hepatocellular Carcinoma

1 reference

12 December 2020

Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor

1 reference

12 December 2020

Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification

1 reference

12 December 2020

Treatment strategy for hepatocellular carcinoma with major portal vein or inferior vena cava invasion: a single institution experience

1 reference

12 December 2020

Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation

1 reference

12 December 2020

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

1 reference

12 December 2020

Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study

1 reference

12 December 2020

Resection of Hepatocellular Carcinoma in Patients Otherwise Eligible for Transplantation

1 reference

12 December 2020

Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.

1 reference

12 December 2020

Whither living donor liver transplantation?

1 reference

12 December 2020

Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis

1 reference

12 December 2020

Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospital

1 reference

12 December 2020

Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal

1 reference

12 December 2020

Results of hepatic resection and transplantation for fibrolamellar carcinoma

1 reference

12 December 2020

Risk of recurrence in hepatitis B-related hepatocellular carcinoma: impact of viral load in late recurrence

1 reference

12 December 2020

Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma

1 reference

12 December 2020

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

12 December 2020

Laparoscopic liver resection facilitates salvage liver transplantation for hepatocellular carcinoma

1 reference

12 December 2020

Transthoracic transdiaphragmatic approach for hepatectomy of Couinaud's segments VII and VIII

1 reference

12 December 2020

Limits and benefits of exclusive transthoracic hepatectomy approach for patients with hepatocellular carcinoma

1 reference

12 December 2020

Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins

1 reference

12 December 2020

10.1007/S00423-012-0911-2

Identifiers

DOI

1 reference

26 August 2017

1 reference